Survival impact of number of removed para-aortic lymph nodes in stage I epithelial ovarian cancer
Authors:
- 19 August 2021
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 305 (2) , 459-465
Abstract
Purpose The survival effect of presence or absence of lymphadenectomy in early-stage epithelial ovarian cancer (EOC) was priorly shown but the effect of number of removed lymph nodes kept in background. We aimed to evaluate the survival impact of number of removed lymph nodes and their localizations in stage I EOC. Methods This study included 182 patients. The best cut-off levels for number of pelvic and para-aortic lymph nodes (PaLN) were 24 and 10, respectively. Univariate and multivariate survival analyses were performed for these cut-offs and other prognostic factors. Results The median age of the patients was 49. The median number of removed pelvic and paraartic lymph nodes were 29 and 9, respectively. The median overall (OS) and progression-free survival (PFS) were 67 and 50 months, respectively. The 5-year OS rate was 89.6%. Recurrence occured in 24 (19.5%) patients. In univariate analyses tumor grade (p: 0.005), pelvic LN number (p: 0.041) and PaLN number (p: 0.004) were the factors that were significantly associated with PFS. Tumor grade and PaLN number were independently and significantly associated with PFS in multivariate analyses (p: 0.015 and p: 0.017, respectively). In OS analyses, age, tumor grade, presence of LVI, number of pelvic and PaLNs were the significantly associated factors (p < 0.05 for all). In multivariate analyses, age and PaLN number were independently and significantly associated with OS (p: 0.011 and p: 0.021, respectively). Conclusions The number and localizations of removed lymph nodes may have a survival affect in stage I EOC. We also think that this study may constitute a kernel point for larger prospective series on lymph node number and lymphatic regions.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based studyInternational Journal of Surgery, 2018
- Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancerJournal of Gynecologic Oncology, 2018
- Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGynecologic Oncology, 2017
- The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancerEuropean Journal of Cancer, 2016
- Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2016
- Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancerJournal of Gynecologic Oncology, 2013
- Lymph node metastasis in stages I and II ovarian cancer: A reviewGynecologic Oncology, 2011
- Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: Implications for surgical stagingGynecologic Oncology, 2011
- Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I–II) Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2011
- Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literatureWorld Journal of Surgical Oncology, 2010